Reply

Affiliations

¹ Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain. Electronic address: jmullol@clinic.cat.
² Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain; Rhinology and Skull Base Surgery Unit, ENT Department, Ramon y Cajal University Hospital, Madrid, Spain.
³ Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain; Hospital Son Espases, Palma de Mallorca, Spain.
⁴ Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain.
⁵ Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain.

Comment

Joaquim Mullol et al. J Allergy Clin Immunol. 2020 Aug.

. 2020 Aug;146(2):463-464.

doi: 10.1016/j.jaci.2020.04.048. Epub 2020 Jun 24.

¹ Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain. Electronic address: jmullol@clinic.cat.
² Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain; Rhinology and Skull Base Surgery Unit, ENT Department, Ramon y Cajal University Hospital, Madrid, Spain.
³ Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain; Hospital Son Espases, Palma de Mallorca, Spain.
⁴ Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain.
⁵ Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Center of Biomedical Research in Respiratory Diseases (CIBERES), Barcelona, Spain.

No abstract available

Comment on

The sense of smell in chronic rhinosinusitis.
Mullol J, Mariño-Sánchez F, Valls M, Alobid I, Marin C. Mullol J, et al. J Allergy Clin Immunol. 2020 Mar;145(3):773-776. doi: 10.1016/j.jaci.2020.01.024. J Allergy Clin Immunol. 2020. PMID: 32145875 No abstract available.
The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps.
Gelardi M, Cassano M, Ciprandi G. Gelardi M, et al. J Allergy Clin Immunol. 2020 Aug;146(2):462-463. doi: 10.1016/j.jaci.2020.04.049. Epub 2020 Jun 24. J Allergy Clin Immunol. 2020. PMID: 32593490 Free PMC article. No abstract available.

1. Gelardi M., Cassano M., Ciprandi G. The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2020;146:462–463. - PMC - PubMed
1. Mullol J., Mariño-Sánchez F., Valls M., Alobid I., Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145:773–776. - PubMed
1. Fokkens W., Lund V., Hopkins C., Hellings P., Kern R., Reitsma S. EPOS2020: European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58:1–464. - PubMed
1. Tokunaga T., Sakashita M., Haruna T., Asaka D., Takeno S., Ikeda H. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study. Allergy. 2015;70:995–1003. - PMC - PubMed
1. Bachert C., Han J.K., Desrosiers M., Hellings P.W., Amin N., Lee S.E. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638–1650. - PubMed